These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23313808)

  • 1. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
    Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S
    Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
    Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
    J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.
    Smith CK; Vivekanandan-Giri A; Tang C; Knight JS; Mathew A; Padilla RL; Gillespie BW; Carmona-Rivera C; Liu X; Subramanian V; Hasni S; Thompson PR; Heinecke JW; Saran R; Pennathur S; Kaplan MJ
    Arthritis Rheumatol; 2014 Sep; 66(9):2532-2544. PubMed ID: 24838349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
    Shao B; Heinecke JW
    J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
    Shao B
    Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Meriwether D; Lee YY; Shahbazian A; Reddy ST
    Clin Rheumatol; 2018 Mar; 37(3):615-622. PubMed ID: 29129008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
    Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
    J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
    Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
    J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Lee YY; Grijalva V; Amjadi S; FitzGerald J; Ranganath VK; Taylor M; McMahon M; Paulus HE; Reddy ST
    Ann Rheum Dis; 2012 Jul; 71(7):1157-62. PubMed ID: 22267330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of dysfunctional high-density lipoprotein levels with myeloperoxidase/paraoxonase-1 ratio in rheumatoid arthritis.
    Alisik T; Alisik M; Nacir B; Ayhan FF; Genc H; Erel O
    Int J Clin Pract; 2021 Jul; 75(7):e14172. PubMed ID: 33756027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
    Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.